Colston, Elizabeth
65  results:
Search for persons X
?
1

Deucravacitinib, a selective, allosteric tyrosine kinase 2 ..:

Blauvelt, Andrew ; Rich, Phoebe ; Sofen, Howard...
Journal of the American Academy of Dermatology.  90 (2024)  4 - p. 775-782 , 2024
 
?
 
?
 
?
4

Deucravacitinib long-term efficacy with continuous treatmen..:

Lebwohl, Mark ; Warren, Richard B. ; Sofen, Howard...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s118 , 2023
 
?
5

43887 Deucravacitinib, an Oral, Selective, Allosteric Tyros..:

Gooderham, Melinda ; Spelman, Lynda ; Imafuku, Shinichi...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB35 , 2023
 
?
7

43110 Deucravacitinib, a Selective Tyrosine Kinase 2 Inhibi..:

Tada, Yayoi ; Imafuku, Shinichi ; Okubo, Yukari...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB147 , 2023
 
?
8

43872 Deucravacitinib, an Oral, Selective, Allosteric Tyros..:

Imafuku, Shinichi ; Okubo, Yukari ; Tada, Yayoi...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB147 , 2023
 
?
 
?
10

43879 Deucravacitinib, an Oral, Selective, Allosteric Tyros..:

Warren, Richard B. ; Armstrong, April W. ; Imafuku, Shinichi...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB147 , 2023
 
?
11

Deucravacitinib versus placebo and apremilast in moderate t..:

Armstrong, April W. ; Gooderham, Melinda ; Warren, Richard B....
Journal of the American Academy of Dermatology.  88 (2023)  1 - p. 29-39 , 2023
 
?
12

39861 Deucravacitinib, a Selective, Allosteric Tyrosine Kin..:

Okubo, Yukari ; Imafuku, Shinichi ; Tada, Yayoi...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB147 , 2023
 
?
13

43827 Deucravacitinib Long-term Efficacy in Patients Origin..:

Lebwohl, Mark ; Warren, Richard B. ; Imafuku, Shinichi...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB35 , 2023
 
?
14

43851 Deucravacitinib Long-term Efficacy With Continuous Tr..:

Lebwohl, Mark ; Warren, Richard B. ; Kircik, Leon...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB35 , 2023
 
1-15